Repository logo
 
Thumbnail Image
Publication

Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors

2024-01-01Journal article Unknown
http://hdl.handle.net/10400.1/26402
Use this identifier to reference this record.

Authors

Chícharo, Ana Teodósio
Lopes, Ana R.
Barreira, Sofia
Pinto, Luísa
Machado, Ana R. Cruz
Capela, Susana

Advisor(s)

Abstract(s)

No safety or efficacy issues arose from using biosimilar TNFi during conception or pregnancy.

Description

Keywords

Pregnancy Rheumatic disorders Mothers Perinatal period Tumor necrosis factor inhibitors Biosimilar pharmaceuticals

URI

http://hdl.handle.net/10400.1/26402

Citation

Research Projects

Organizational Units

Journal Issue

Publisher

Oxford University Press

DOI

10.1093/rap/rkae044

Collections

ULS_10.1-MED-Artigos

CC License

cclicense-by

Altmetrics